Nutex Health Inc. (NUTX)

Nutex Health Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	120.57	52.1	-45.79	-424.78	132.59	105.97
Depreciation & Amortization	20.62	18.97	17.59	13.13	7.66	5.9
Other Amortization	0.99	1.04	1.21	1.95	0.05	0.06
Asset Writedown & Restructuring Costs	-0.01	7.54	30.22	398.14	-	-
Stock-Based Compensation	134.21	16.55	2.84	0.19	-	-
Other Operating Activities	154.39	30.8	-3.15	-2.34	30.37	40.76
Change in Accounts Receivable	-328.42	-173.41	-4.58	58.08	-6.62	-71.23
Change in Inventory	-0.9	0.54	0.14	-0.72	-1.09	-0.83
Change in Accounts Payable	37.21	-10.72	-2.25	9.69	6.27	6.23
Change in Income Taxes	-12.1	26.53	-	-	-	-
Change in Other Net Operating Assets	51.22	53.2	5.03	-2.73	4.2	-0.19
Operating Cash Flow	177.79	23.15	1.26	50.61	173.43	86.67
Operating Cash Flow Growth	733.81%	1742.79%	-97.52%	-70.82%	100.10%	614.84%
Capital Expenditures	-3.51	-2.3	-9.5	-14.63	-36.93	-61.19
Cash Acquisitions	-	-	-0.7	12.72	-	-
Divestitures	-0	-0.36	-1.04	-2.42	-0.05	-
Investment in Securities	-2.94	-2.94	-	-	-	-
Investing Cash Flow	-3.51	-5.61	-11.24	-4.34	-36.98	-61.19
Short-Term Debt Issued	-	2.26	2.34	2.62	-	1
Long-Term Debt Issued	-	7.01	21.86	0.82	19.61	57.17
Total Debt Issued	6.45	9.28	24.2	3.44	19.61	58.17
Short-Term Debt Repaid	-	-2.08	-1.59	-0.07	-0.86	-2.67
Long-Term Debt Repaid	-	-14.6	-19.96	-8.96	-21.97	-14.24
Total Debt Repaid	-20.92	-16.68	-21.56	-9.03	-22.84	-16.91
Net Debt Issued (Repaid)	-14.47	-7.4	2.65	-5.59	-3.22	41.27
Issuance of Common Stock	4.28	14.93	0.3	9.28	21.75	10.03
Common Dividends Paid	-	-	-	-34.35	-111.69	-45.63
Other Financing Activities	-44.95	-6.44	-5.21	-17.47	-32.69	-13.63
Financing Cash Flow	-55.14	1.09	-2.27	-48.13	-125.85	-7.97
Net Cash Flow	119.14	18.64	-12.25	-1.86	10.6	17.51
Free Cash Flow	174.28	20.85	-8.24	35.97	136.51	25.48
Free Cash Flow Growth	761.12%	-	-	-73.65%	435.68%	-
Free Cash Flow Margin	17.76%	4.34%	-3.33%	16.41%	41.17%	9.30%
Free Cash Flow Per Share	25.58	3.80	-1.87	8.50	34.54	6.45
Cash Interest Paid	18.48	3.47	1.64	4.62	4.1	3.25
Cash Income Tax Paid	69.34	0.8	0.85	8.23	0.34	0.18
Levered Free Cash Flow	115.6	13.19	0.47	53.4	81.1	-33.15
Unlevered Free Cash Flow	128.55	24.6	9.46	59.26	84.92	-29.19
Change in Working Capital	-252.98	-103.85	-1.66	64.32	2.75	-66.02

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q